479630-02-9 Usage
Molecular structure
The compound has a 4-piperidinepropanoic acid core structure, with a beta-keto group, a BOC protecting group, and a methyl ester group.
Functional groups
The compound contains an ester group, a ketone group, and a methyl group.
Protecting group
The BOC group serves as a protecting group for the beta-keto functionality, allowing for selective reactions.
Use in synthesis
The compound is commonly used as a building block in the synthesis of various pharmaceuticals and biologically active compounds.
Application in pharmaceutical industry
It is often used in the development of potential drug candidates or as a precursor for the synthesis of complex molecules.
Chemical properties
The specific chemical properties of the compound are not provided in the material, but its use as a building block and a precursor in synthesis suggests that it has reactive functional groups that can undergo various chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 479630-02-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,9,6,3 and 0 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 479630-02:
(8*4)+(7*7)+(6*9)+(5*6)+(4*3)+(3*0)+(2*0)+(1*2)=179
179 % 10 = 9
So 479630-02-9 is a valid CAS Registry Number.
479630-02-9Relevant articles and documents
Synthesis and characterization of novel methyl (3)5-(n-boc-piperidinyl)-1h-pyrazole-4-carboxylates
?a?kus, Algirdas,Arba?iauskien?, Egl?,Bieliauskas, Aurimas,Dagilien?, Migl?,Kederien?, Vilija,Kleizien?, Neringa,Matulevi?iūt?, Gita,Mili?iūnait?, Vaida,Ragait?, Greta,Sl?k, Frank A.
, (2021)
Series of methyl 3-and 5-(N-Boc-piperidinyl)-1H-pyrazole-4-carboxylates were developed and regioselectively synthesized as novel heterocyclic amino acids in their N-Boc protected ester form for achiral and chiral building blocks. In the first stage of the
DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
-
Page/Page column 39; 41-42; 121; 128-129, (2020/01/24)
The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.
COMPOUNDS AND COMPOSITIONS AS TGR5 AGONISTS
-
Page/Page column 62, (2012/06/30)
The invention provides compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with TGR5.
